IRIS PubliCatt

Fargnoli, Maria Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.357
EU - Europa 883
AS - Asia 507
AF - Africa 25
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 2.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.343
SE - Svezia 279
SG - Singapore 252
IT - Italia 182
CN - Cina 134
IE - Irlanda 115
DE - Germania 97
ID - Indonesia 78
RU - Federazione Russa 49
GB - Regno Unito 39
BE - Belgio 23
CI - Costa d'Avorio 23
CZ - Repubblica Ceca 17
FI - Finlandia 17
FR - Francia 17
HK - Hong Kong 16
CA - Canada 14
IN - India 12
UA - Ucraina 10
CH - Svizzera 9
RO - Romania 9
NL - Olanda 7
BR - Brasile 4
ES - Italia 3
JP - Giappone 3
MY - Malesia 3
PE - Perù 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AU - Australia 2
CL - Cile 2
EU - Europa 2
IR - Iran 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
DK - Danimarca 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
LT - Lituania 1
LV - Lettonia 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VN - Vietnam 1
Totale 2.790
Salva come PNG Salva come JPEG
Città #
Chandler 407
Singapore 185
Dublin 115
Ann Arbor 98
Ashburn 97
Jakarta 78
Boston 52
Bremen 52
Princeton 51
New York 46
Milan 44
San Mateo 44
Beijing 39
Moscow 33
Wilmington 30
Rome 26
Abidjan 23
Brussels 23
Woodbridge 17
Hong Kong 16
Brno 15
Washington 15
Cattolica 14
Los Angeles 13
Helsinki 11
London 11
Chicago 10
Jacksonville 10
Frankfurt am Main 9
Nanjing 9
Mountain View 8
Redwood City 8
Munich 7
Toronto 7
Dearborn 6
Houston 6
Monza 6
Norwalk 6
Seattle 6
Dallas 5
Fairfield 5
Ottawa 5
Padova 5
Amsterdam 4
Augusta 4
Boydton 4
Changsha 4
Clearwater 4
Paris 4
Boardman 3
Bucharest 3
Busto Arsizio 3
Catania 3
Detroit 3
Edinburgh 3
La Spezia 3
Lausanne 3
Leawood 3
Lima 3
Madrid 3
Marburg 3
Nanchang 3
North Charleston 3
Regensdorf 3
Ansbach 2
Auckland 2
Bologna 2
Brdo 2
Cambridge 2
Campagna 2
Castelnuovo Rangone 2
Comelico Superiore 2
Dehradun 2
Duncan 2
Esslingen am Neckar 2
Fort Worth 2
Fremont 2
Gozzano 2
Guangzhou 2
Guglionesi 2
Hebei 2
Kuala Lumpur 2
Lappeenranta 2
Lawrence 2
Monmouth Junction 2
New Delhi 2
Perugia 2
Redmond 2
Sacramento 2
San Francisco 2
Slough 2
São Paulo 2
Teramo 2
Timisoara 2
Trento 2
Vienna 2
Zhengzhou 2
Zurich 2
Andover 1
Arezzo 1
Totale 1.812
Salva come PNG Salva come JPEG
Nome #
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 112
Cutaneous squamous cell carcinoma. Italian guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines 104
A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosis 103
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 75
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 63
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 61
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 60
Real-world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study 57
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study 56
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 55
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 55
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 54
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 54
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study 54
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic 53
5-aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an italian study in the real-life setting 53
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 51
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019 51
Management of cutaneous melanoma: Comparison of the leading international guidelines updated to the 8th American Joint Committee on Cancer staging system and workup proposal by the Italian Society of Dermatology 51
Pruritus characteristics in a large Italian cohort of psoriatic patients 51
ΜelanoQ: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum Consortium 50
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 48
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention 48
Sclerosing nevus with pseudomelanomatous features: dermoscopic and confocal aspects 48
Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp 44
Molecular alterations in basal cell carcinoma subtypes 44
Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’ 42
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 42
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 42
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 42
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 40
Clinical determinants of complete response to vismodegib in locally advanced basal cell carcinoma: a multicentre experience 40
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition 39
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 39
Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018)) 37
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family 36
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities 35
Treatment adherence with diclofenac 3% gel among patients with multiple actinic keratoses: an integrated low-intensity intervention program versus standard-of-care 35
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas 35
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 35
Italian expert consensus paper on the management of patients with actinic keratoses 34
Psoriasis and its management in women of childbearing age: Tools to increase awareness in dermatologists and patients 34
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma 34
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 33
Response to: Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’ 33
Advanced Cutaneous Squamous Cell Carcinoma: Italian Multicentric Retrospective Analysis of Patient Profiles and Therapeutic Approaches 32
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 32
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study 31
Contribution of common genetic variants to familial aggregation of disease and implications for sequencing studies 28
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study 27
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022 26
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 26
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 25
Self-Assessment Questionnaire on Patient-Physician Concordance on Nevus Self-Count and Models Development to Predict High-Risk Phenotype >50 Nevi 24
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience 24
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference 23
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients 23
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness 22
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics 22
Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study 21
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference 19
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022 18
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study 18
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients 18
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation 17
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 16
Telomeres and telomerase in cutaneous squamous cell carcinoma 16
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement 16
Update on the Management of Pediatric Psoriasis: An Italian Consensus 16
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022 15
The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe 15
AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST 15
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls 15
Mycosis fungoides: creation of a prospective, interdisciplinary and multicenter study in central Italy 10
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium 10
Totale 2.882
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202059 0 0 0 0 6 1 7 14 7 7 14 3
2020/2021141 3 11 2 3 6 5 16 44 9 7 29 6
2021/2022438 15 8 8 17 29 8 1 64 32 34 108 114
2022/2023987 109 130 71 177 77 118 28 81 140 16 30 10
2023/2024730 24 178 52 52 46 101 55 10 15 26 85 86
2024/2025371 41 27 104 55 144 0 0 0 0 0 0 0
Totale 2.882